Lipid mediator class switching during acute inflammation: signals in resolution
The DOI matches its Crossref record; 41 of the 42 references it cites were found in a registry or an index.
Abstract
Leukotrienes (LTs) and prostaglandins (PGs) amplify acute inflammation, whereas lipoxins (LXs) have unique anti-inflammatory actions. Temporal analyses of these eicosanoids in clinical and experimental exudates showed early coordinate appearance of LT and PG with polymorphonuclear neutrophil (PMN) recruitment. This was followed by LX biosynthesis, which was concurrent with spontaneous resolution. Human peripheral blood PMNs exposed to PGE2 (as in exudates) switched eicosanoid biosynthesis from predominantly LTB4 and 5-lipoxygenase (5-LO)-initiated pathways to LXA4, a 15-LO product that "stopped" PMN infiltration. These results indicate that first-phase eicosanoids promote a shift to anti-inflammatory lipids: functionally distinct lipid-mediator profiles switch during acute exudate formation to "reprogram" the exudate PMNs to promote resolution.
Overview
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“Prostaglandin E2 (PGE2) and D2 rapidly initiate the resolution process by inducing the expression of lipid mediators with both anti-inflammatory and pre-resolution functions, e.g., lipoxins [96, 97], resolvins and protectins [98–100], a process known as lipid-mediator class switch [97].”
From Transition from inflammation to proliferation: a critical step during wound healing (2016) · cites this paper as [97]
Citations
Cites
Inflammation. Basic principles and clinical correlates
(1989) · Biomedicine & Pharmacotherapy · doi:10.1016/0753-3322(89)90156-x · Cited by 2,393
Inducible cyclooxygenase may have anti-inflammatory properties
Gilroy, D. W., Colville-Nash, P. R., Willis, D., Chivers, J., Paul-Clark, M. J., & Willoughby, D. A. (1999) · Nature Medicine · doi:10.1038/9550 · Cited by 1,242
Godson, C., Mitchell, S., Harvey, K., Petasis, N. A., Hogg, N., & Brady, H. R. (2000) · The Journal of Immunology · doi:10.4049/jimmunol.164.4.1663 · Cited by 638
Inflammation: Basic Principles and Clinical Correlates
Ehrlich, G. E. (2000) · JAMA: The Journal of the American Medical Association · doi:10.1001/jama.283.1.123 · Cited by 622
Shinmura, K., Tang, X.-L., Wang, Y., Xuan, Y.-T., Liu, S.-Q., Takano, H., Bhatnagar, A., & Bolli, R. (2000) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.97.18.10197 · Cited by 381
Swan, S. K., Rudy, D. W., Lasseter, K. C., Ryan, C. F., Buechel, K. L., Lambrecht, L. J., Pinto, M. B., Dilzer, S. C., Obrda, O., Sundblad, K. J., et al. (2000) · Annals of Internal Medicine · doi:10.7326/0003-4819-133-1-200007040-00002 · Cited by 339
Design of Lipoxin A4 Stable Analogs That Block Transmigration and Adhesion of Human Neutrophils
Serhan, C. N., Maddox, J. F., Petasis, N. A., Akritopoulou-Zanze, I., Papayianni, A., Brady, H. R., Colgan, S. P., & Madara, J. L. (1995) · Biochemistry · doi:10.1021/bi00044a041 · Cited by 327
Self-citationActivation of the NF-κB Pathway by Inflammatory Stimuli in Human Neutrophils
McDonald, P. P., Bald, A., & Cassatella, M. A. (1997) · Blood · doi:10.1182/blood.v89.9.3421 · Cited by 324
Prostaglandins, Aspirin-like Drugs and the Oedema of Inflammation
MONCADA, S., FERREIRA, S. H., & VANE, J. R. (1973) · Nature · doi:10.1038/246217a0 · Cited by 312 · cited 1×
“Although PGE 2 induces reactions that mediate several of the cardinal features of inflammation (for example, edem”
BackgroundTessier, P. A., Naccache, P. H., Clark-Lewis, I., Gladue, R. P., Neote, K. S., & McColl, S. R. (1997) · The Journal of Immunology · doi:10.4049/jimmunol.159.7.3595 · Cited by 233
Research works printed but not linked: 2
- Light, R. W. Pleural Diseases (Lea & Febiger, Philadelphia, 1990).
- Clish, C. B. et al. Local and systemic delivery of a stable aspirin-triggered lipoxin prevents neutrophil recruitment in vivo. Proc. Natl Acad Sci USA 96, 8247–8252 (1999). · DOI · Paper page
Cited by
Items 901–1,000 of 1,000
Dominguez, E. C., Phandthong, R., Nguyen, M., Ulu, A., Guardado, E. S., Sveiven, S., Talbot, P., & Nordgren, T. M. (2022) · Cancers · doi:10.3390/cancers14081900 · Cited by 20
“SPMs, including AT-RvD1, assist in wound repair, tissue regeneration, and promotion of the resolution of inflammation via binding to surface receptors on structural and immune cells [19,24,66].”
BackgroundPolyunsaturated Fatty Acids and Their Immunomodulatory Actions in Periodontal Disease
Panezai, J., & Dyke, T. E. V. (2023) · Nutrients · doi:10.3390/nu15040821 · Cited by 22
“SPMs orchestrate the events involved in the resolution of acute inflammation by reducing further leukocytic infiltration, stimulating efferocytosis and exerting anti-inflammatory actions that promote healing [20].”
BackgroundEosinophil Phenotypes Are Functionally Regulated by Resolvin D2 during Allergic Lung Inflammation
Brüggemann, T. R., Peh, H. Y., Tavares, L. P., Nijmeh, J., Shay, A. E., Rezende, R. M., Lanser, T. B., Serhan, C. N., & Levy, B. D. (2023) · American Journal of Respiratory Cell and Molecular Biology · doi:10.1165/rcmb.2023-0121oc · Cited by 20
Self-citationImmunomodulation of periodontitis with SPMs
Sahni, V., & Dyke, T. E. V. (2023) · Frontiers in Oral Health · doi:10.3389/froh.2023.1288722 · Cited by 23
Influenza A virus selectively elevates prostaglandin E2 formation in pro-resolving macrophages
Jordan, P. M., Günther, K., Nischang, V., Ning, Y., Deinhardt‐Emmer, S., Ehrhardt, C., & Werz, O. (2023) · iScience · doi:10.1016/j.isci.2023.108775 · Cited by 16
“AsPGE 2 wasshowntoinducetheswitchfrompro-inflammatorytowardinflammation-resolvingLM, 32,33 itistemptingtospeculate that also the IAV-mediated induction of PGE 2 formation in pro-resolving M2 macrophages might contribute to such LM class switching.”
BackgroundKarnam, S., Maurya, S., Ng, E., Choudhary, A., Thobani, A., Flanagan, J. G., & Gronert, K. (2024) · Acta Neuropathologica Communications · doi:10.1186/s40478-024-01767-2 · Cited by 17
“A key feature of an immune-regulatory and pro-resolving phenotype of PMN is high expression of 15-LOX to enable generation of lipoxins [15, 29].”
BackgroundSelf-citationCarmo, S. D., Kautzmann, M.-A. I., Bhattacharjee, S., Jun, B., Steinberg, C., Emmerson, J. T., Malcolm, J. C., Bonomo, Q., Bazan, N. G., & Cuello, A. C. (2024) · Journal of Neuroinflammation · doi:10.1186/s12974-024-03184-7 · Cited by 50
“The resolution of inflammation is, in part, controlled by a switch in the production of lipid mediators from a pro-inflammatory to a pro-resolving class [22].”
BackgroundHirahashi, J., Kawahata, K., Arita, M., Iwamoto, R., Hishikawa, K., Honda, M., Hamasaki, Y., TANAKA, M., Okubo, K., Kurosawa, M., et al. (2014) · Scientific Reports · doi:10.1038/srep06406 · Cited by 18
Chen, Q., Zhou, W., Su, Z., Huang, Q.-S., Jiang, J., & Chen, Q. (2009) · Fertility and Sterility · doi:10.1016/j.fertnstert.2009.02.013 · Cited by 18
“Resolution is an active process, and acute inflammatory response lasts for approximately 3–4 days (27).”
BackgroundChen, Y., Liu, Q., Xie, H., Yin, S., Wu, L., Yu, X., Fan, L., & Lin, L. (2019) · Chinese Journal of Integrative Medicine · doi:10.1007/s11655-019-3078-7 · Cited by 18
“Despite their effect in relieving acute infl ammation, the anti-infl ammatory strategy may weaken the immune system, increase the chances of infection, delay recovery from injury, turn acute inflammation into chronic, or increase other risks.((9)) Furthermore, long-term and large-sample control studies have shown that…”
BackgroundThe lipid paradox in neuroprogressive disorders: Causes and consequences
Morris, G., Berk, M., Walder, K., O’Neil, A., Maes, M., & Puri, B. K. (2021) · Neuroscience & Biobehavioral Reviews · doi:10.1016/j.neubiorev.2021.06.017 · Cited by 17
Mastromarino, M., Favia, M., Schepetkin, I. A., Kirpotina, L. N., Trojan, E., Niso, M., Carrieri, A., Leśkiewicz, M., Regulska, M., Darida, M., et al. (2022) · Journal of Medicinal Chemistry · doi:10.1021/acs.jmedchem.1c02203 · Cited by 18
The role of 15-LOX-1 in colitis and colitis-associated colorectal cancer
Mao, F., Wang, M., Wang, J., & Xu, W. (2015) · Inflammation Research · doi:10.1007/s00011-015-0852-7 · Cited by 22
“Levy’s study showed that forskolin and PGE2 can induce 15-LOX-1 expression from neutrophils [36].”
BackgroundKowal, K., Gielicz, A., & Sanak, M. (2017) · Clinical & Experimental Allergy · doi:10.1111/cea.12990 · Cited by 18
“Prostaglandin D2 activates PD2 receptor involved in chemotaxis of lymphocytes, eosinophils and basophils, whereas, bronchoconstrictor activity of PGD2 and isoprostanes is mediated by thromboxane receptor.(3,4,10) In asthmatic patients, the enhanced production of 5-LOX and COX-derived eicosanoids after allergen challen…”
BackgroundInfluentialMattos, M. S., Lopes, M. E., de Araujo, A., Alvarenga, D. M., Nakagaki, B. N., Mafra, K., de Miranda, C. D. M., Diniz, A. B., Antunes, M. M., Lopes, M. A. F., et al. (2020) · Journal of Leukocyte Biology · doi:10.1002/jlb.1ma0420-634r · Cited by 23
Lipid mediator networks and leukocyte transmigration
Louis, N. A., Hamilton, K. E., & Colgan, S. P. (2005) · Prostaglandins Leukotrienes and Essential Fatty Acids · doi:10.1016/j.plefa.2005.05.006 · Cited by 17
Huang, Y., Dong, S., Zhang, Y., Zhang, Y., Guo, Y., Shi, J., Li, X., Liu, S., Chen, Y., & Yu, J. (2025) · International Immunopharmacology · doi:10.1016/j.intimp.2024.113941 · Cited by 19
Signal integration in forward and reverse neutrophil migration: Fundamentals and emerging mechanisms
Rocha-Gregg, B. L., & Huttenlocher, A. (2021) · Current Opinion in Cell Biology · doi:10.1016/j.ceb.2021.07.002 · Cited by 19
CX3CL1(+) Microparticles-Induced MFG-E8 Enhances Apoptotic Cell Clearance by Alveolar Macrophages
Tsai, W.-H., Chang, S.-C., Lin, Y.-C., & Hsu, H.-C. (2021) · Cells · doi:10.3390/cells10102583 · Cited by 16
Plasma Levels of Polyunsaturated Fatty Acids and Adverse Kidney Outcomes
Koh, H. B., Kim, H. W., Joo, Y. S., Jung, C., Kim, H. J., Chang, T. I., Park, J. T., Yoo, T., Kang, S., & Han, S. H. (2024) · American Journal of Kidney Diseases · doi:10.1053/j.ajkd.2023.12.020 · Cited by 19
Underneath the Gut–Brain Axis in IBD—Evidence of the Non-Obvious
Boldyreva, L. V., Evtushenko, A. A., Lvova, M. N., Morozova, K. N., & Владимировна, К. Е. (2024) · International Journal of Molecular Sciences · doi:10.3390/ijms252212125 · Cited by 16
Li, G., Wu, P., Xu, Y., Yu, Y., Sun, L., Zhu, L., & Ye, D. (2009) · BMC Musculoskeletal Disorders · doi:10.1186/1471-2474-10-57 · Cited by 15
“It is defined as a highly coordinated and process involving changes from gene transcription to local mediators generation within the resolution phase, not just in vivo dwindling with time of chemotaxic stimuli at the site of inflammation [50-52].”
Mackel, J. J., Garth, J. M., Blackburn, J. P., Jones, M., & Steele, C. H. (2020) · The Journal of Immunology · doi:10.4049/jimmunol.1900808 · Cited by 18
“Select lipid species, such as lipoxin A4 produced by 12/15-LOX, have noted proresolution functions and are thought to be produced later in a given response in an effort to temper inflammation and damage (36).”
BackgroundStefanson, A. L., & Bakovic, M. (2020) · Nutrition Research · doi:10.1016/j.nutres.2020.06.014 · Cited by 18
Younes, R., LeBlanc, C.-A., & Hiram, R. (2022) · Biomolecules · doi:10.3390/biom12050720 · Cited by 17
Inflammation resolved by retinoid X receptor‐mediated inactivation of leukotriene signaling pathways
Kalsotra, A., Du, L., Wang, Y., Ladd, P. A., Kikuta, Y., Duvic, M. A., Boyd, A. S., Keeney, D. S., & Strobel, H. W. (2007) · The FASEB Journal · doi:10.1096/fj.07-9244com · Cited by 16
Resolvins and protectins: novel lipid mediators in anti-inflammation and resolution
Serhan, C. N. (2006) · Scandinavian Journal of Food & Nutrition · doi:10.1080/17482970601066298 · Cited by 18
“However, in sharp contrast, it has become clear that counter-regulatory substances, such as lipoxins, are generated during the resolution of acute inflammation to serve in healthy termination of an acute response (34, 35).”
BackgroundSelf-citationRuhanen, H., Haridas, P. A. N., Minicocci, I., Taskinen, J., Palmas, F., Costanzo, A. D., D’Erasmo, L., Metso, J., Partanen, J., Dalli, J., et al. (2020) · Biochimica et Biophysica Acta (BBA) - Molecular and Cell Biology of Lipids · doi:10.1016/j.bbalip.2020.158679 · Cited by 18
“They are generally referred to as pro-inflammatory mediators [56], but especially PGE2 is also important for the lipid mediator class switching at the beginning of the resolution phase as it decreases the production of pro-inflammatory leukotriene B4 (LTB4) species [57].”
BackgroundTaylor, A. L., Bonventre, J. V., Uliasz, T. F., Hewett, J. A., & Hewett, S. J. (2008) · Journal of Neurochemistry · doi:10.1111/j.1471-4159.2008.05527.x · Cited by 18
Lipoxins and Aspirin-Triggered Lipoxins in Airway Responses
Levy, B. D., Sanctis, G. T. D., Devchand, P. R., Kim, E., Ackerman, K. G., Schmidt, B. A. R., Szczeklik, W., Drazen, J. M., & Serhan, C. N. (2003) · Advances in experimental medicine and biology · doi:10.1007/978-1-4419-9194-2_5 · Cited by 16
“Analyses of the time course of appearance of eicosanoids during acute inflammation has revealed the early coordinate appearance of LT andPG with leukocyte recruitment followed by LX during resolution [3].”
BackgroundSelf-citationKolmert, J., Piñeiro‐Hermida, S., Hámberg, M., Gregory, J. A., López, I. P., Fauland, A., Wheelock, C. E., Dahlén, S., Pichel, J. G., & Adner, M. (2018) · Prostaglandins & Other Lipid Mediators · doi:10.1016/j.prostaglandins.2018.05.005 · Cited by 16
“Some products exhibits properties suggesting a role to promote resolution of inflammation and the name specialized pro-resolving lipid mediators (SPMs) has therefore been introduced [6,7].”
BackgroundSoták, M., Rajan, M. R., Clark, M., Harms, M., Rani, A., Kraft, J. D., Tandio, D., Shen, T., Borkowski, K., Fiehn, O., et al. (2022) · iScience · doi:10.1016/j.isci.2022.104602 · Cited by 15
“Prostaglandins have dual roles in regulating inflammatory responses and induce the expression of lipoxygenase (LOX) required for SPM production (Levy et al., 2001).”
BackgroundResolution Potential of Necrotic Cell Death Pathways
Mázló, A., Tang, Y., Jenei, V., Brauman, J., Yousef, H., Bácsi, A., & Koncz, G. (2022) · International Journal of Molecular Sciences · doi:10.3390/ijms24010016 · Cited by 19
Distinct responses of lung and liver macrophages to acute endotoxemia
Connor, A. J., Chen, L. C., Joseph, L. B., Laskin, J. D., & Laskin, D. L. (2012) · Experimental and Molecular Pathology · doi:10.1016/j.yexmp.2012.09.006 · Cited by 15
“Eicosanoids generated via 12/15-LOX are thought to promote the resolution of inflammation (Levy et al., 2001; Serhan et al., 2008).”
Dondoni, L., Scarparo, R. K., Kantarcı, A., Dyke, T. E. V., Figueiredo, J., & Júnior, E. L. B. (2013) · International Endodontic Journal · doi:10.1111/iej.12224 · Cited by 15
Birukov, K. G., & Karki, P. (2018) · Pulmonary Circulation · doi:10.1177/2045893217752660 · Cited by 16
“In addition, the change in repertoire of pro-inflammatory bioactive lipid mediators secreted during the acute phase of ALI to anti-inflammatory lipid mediators such as lipoxins, resolvins, and protectins synthesized during ALI resolution drives the recovery of inflammation.(33,34) Barrier-promoting agonists and mechan…”
BackgroundThe role of lipoxin in regulating tumor immune microenvironments
Zhang, T., Hao, H., & Zhou, X. (2019) · Prostaglandins & Other Lipid Mediators · doi:10.1016/j.prostaglandins.2019.106341 · Cited by 16
Cell-Inspired Biomaterials for Modulating Inflammation
Bender, E. C., Kraynak, C. A., Huang, W., & Suggs, L. J. (2021) · Tissue Engineering Part B Reviews · doi:10.1089/ten.teb.2020.0276 · Cited by 16
“44 Lipid class switching, the M1 to M2 macrophage population phenotype transition, and the cytokine paracrine mediators of the immune system coordinate the robust resolution of inflammation and promote tissue repair.”
Expression regulation of MAO isoforms in monocytic cells in response to Th2 cytokines.
Chaitidis, P., Billett, E. E., Kuban, R. ‐., Ungethuem, U., & Kühn, H. (2005) · PubMed · Cited by 18
Science and Practice of Pediatric Critical Care Medicine
Wheeler, D. S., Shanley, T. P., & Wong, H. R. (2008) · Springer eBooks · doi:10.1007/978-1-84800-921-9 · Cited by 16
Synthesis, Structural Confirmation, and Biosynthesis of 22-OH-PD1n-3 DPA
Nesman, J. I., Primdahl, K. G., Tungen, J. E., Palmas, F., Dalli, J., & Hansen, T. V. (2019) · Molecules · doi:10.3390/molecules24183228 · Cited by 16
“Over the last century, inflammation has been the topic of numerous studies at the biomolecular and the cellular levels [3].”
BackgroundAhmad, N. S., Tan, T. L., Arifin, K. T., Ngah, W. Z. W., & Yusof, Y. A. M. (2020) · PLoS ONE · doi:10.1371/journal.pone.0230285 · Cited by 15
“Due to their natural role in the pathophysiology of inflammation and overall contribution to modulating the inflammatory response, eicosanoids are also considered potential inflammatory markers of BSS [34,35,47,55].”
Liver: The formation and actions of aspirin-triggered lipoxins
Clària, J., & Planagumà, A. (2005) · Prostaglandins Leukotrienes and Essential Fatty Acids · doi:10.1016/j.plefa.2005.05.017 · Cited by 15
Dietary lipids and intestinal inflammatory disease
Innis, S. M., Pinsk, V., & Jacobson, K. (2006) · The Journal of Pediatrics · doi:10.1016/j.jpeds.2006.06.058 · Cited by 15
Products of 15‐lipoxygenase: are they important in asthma?
Nasser, S. M., & Lee, T. H. (2002) · Clinical & Experimental Allergy · doi:10.1046/j.1365-2222.2002.01529.x · Cited by 15
The Role of Phospholipases in Lipid Modification and Atherosclerosis
Ghesquiere, S. A. I., Hofker, M. H., & de Winther, M. P. J. (2005) · Cardiovascular Toxicology · doi:10.1385/ct:5:2:161 · Cited by 18
Exploring machine learning strategies for single-cell transcriptomic analysis in wound healing
Cui, J., Wang, M., Lin, C., Xu, X., & Zhang, Z. (2025) · Burns & Trauma · doi:10.1093/burnst/tkaf032 · Cited by 15
“This process not only clears cellular debris but also initiates the production of specialized pro-resolving mediators, such as lipoxins, which further modulate the inflammatory response [32].”
Siglec-F + neutrophils promote the resolution of acute lung injury through ALOX15 induction
Tavares, L. P., Brüggemann, T. R., Cagnina, R. E., Nshimiyimana, R., Villaseñor-Altamirano, A. B., Rezende, R. M., Lanser, T. B., Liu, X., Bateman, M. E., Krishnamoorthy, N., et al. (2025) · Science Immunology · doi:10.1126/sciimmunol.aeb2657 · Cited by 16
Self-citationDubé, L., Spahis, S., Lachaîne, K., Lemieux, A., Monhem, H., Poulin, S.-M., Randoll, C., Travaillaud, E., Ould-Chikh, N.-E.-H., Marcil, V., et al. (2022) · Antioxidants and Redox Signaling · doi:10.1089/ars.2021.0156 · Cited by 15
“They are formed as a result of different multi-cellular host responses to infections and inflammation (115).”
IRG1/ACOD1 promotes neutrophil reverse migration and alleviates local inflammation
Ji, J., Zhong, H., Li, Y., Billiar, T. R., Wilson, M. A., Scott, M. J., & Fan, J. (2024) · Journal of Leukocyte Biology · doi:10.1093/jleuko/qiae110 · Cited by 16
Shelnut, E. L., Nikas, S. P., Finnegan, D. F., Chiang, N., Serhan, C. N., & Makriyannis, A. (2015) · Tetrahedron Letters · doi:10.1016/j.tetlet.2015.01.164 · Cited by 13
Self-citationRepair Mechanisms in Oxidant-Driven Chronic Inflammatory Disease
Deeb, R. S., & Hajjar, D. P. (2016) · American Journal Of Pathology · doi:10.1016/j.ajpath.2016.03.001 · Cited by 15
“In particular, M1 activation results in leukotriene B4 (LTB4) release among other inflammatory molecules that further attract and activate several inflammatory cell types required in host defense.(98) Notably, the COX products prostaglandins D2 and F2a can constrict bronchial airways (Figure 2).”
BackgroundBrücher, B. L. D. M., & Jamall, I. S. (2019) · 4open · doi:10.1051/fopen/2018008 · Cited by 16
Prostaglandin E2 Inhibits the Ability of Neutrophils to Kill Listeria monocytogenes
Pitts, M. G., & D’Orazio, S. E. F. (2019) · The Journal of Immunology · doi:10.4049/jimmunol.1900201 · Cited by 16
“(50) have proposed that accumulation of one eicosanoid can lead to an enzymatic changeover to production of another class and ultimate resolution, a temporal phenomenon they called an eicosanoid switch.”
Backgroundvon Hegedus, J. H., Kahnt, A. S., Ebert, R., Heijink, M., Toes, R. E. M., Giera, M. A., & Ioan‐Facsinay, A. (2020) · Biochimica et Biophysica Acta (BBA) - Molecular and Cell Biology of Lipids · doi:10.1016/j.bbalip.2020.158740 · Cited by 18
Biguetti, C. C., Couto, M. C. R., da Silva, A. C. R., Shindo, J. V. T. C., Vinicius Matheus, R. O. S. A., Shinohara, A. L., Andreo, J. C., Duarte, M. A. H., Wang, Z., Brotto, M., et al. (2020) · Frontiers in Endocrinology · doi:10.3389/fendo.2020.00484 · Cited by 14
Lipid Mediators in Inflammation
Bennett, M., & Gilroy, D. W. (2017) · ASM Press eBooks · doi:10.1128/9781555819194.ch19 · Cited by 22
Pro-resolving and anti-inflammatory effects of resolvins and protectins in rheumatoid arthritis
Zhang, X., & Zhang, H. (2023) · Inflammopharmacology · doi:10.1007/s10787-023-01343-5 · Cited by 15
“…google. com/ search? sca_ esv= 56877 5834& rlz= 1C1GC EU_ enIN9 16IN9 16&q= preso lvent & spell= 1& sa= X& ved= 2ahUK Ewjg4 8GczM qBAxU 0yzgG HUcNC 8wQkeEpresolvent mediators, including LXs, RVs, and PDs, which play a crucial role in the resolution phase of inflammation (Levy et al. 2001) (Fig.”
Araujo, P. W., Lucena, E., Yang, Y., Ceemala, B., Mengesha, Z. T., & Holen, E. (2014) · Journal of Chromatography B · doi:10.1016/j.jchromb.2014.01.018 · Cited by 16
Differential Gene Expression in Thrombomodulin (TM; CD141)+ and TM− Dendritic Cell Subsets
Toda, M., Shao, Z., Yamaguchi, K. D., Takagi, T., D’Alessandro‐Gabazza, C. N., Taguchi, O., Salamon, H., Leung, L. L. K., Gabazza, E. C., & Morser, J. (2013) · PLoS ONE · doi:10.1371/journal.pone.0072392 · Cited by 19
“These changes will be expected to reduce pro-inflammatory prostaglandins synthesis and increase production of the antiinflammatory lipoxins [24,25].”
BackgroundLopes‐Ferreira, M., Gomes, E. M., Bruni, F. M., Ferreira, M. J., Charvet, P., & Lima, C. (2014) · Toxicon · doi:10.1016/j.toxicon.2014.08.007 · Cited by 15
“This class switch in eicosanoid production, from leukotrienes and prostaglandins to lipoxins (Levy et al., 2001) are produced locally during the initiation of acute inflammatory response.”
BackgroundAspirin Actions in Treatment of NSAID-Exacerbated Respiratory Disease
Sehanobish, E., Asad, M., Barbi, M., Porcelli, S. A., & Jerschow, E. (2021) · Frontiers in Immunology · doi:10.3389/fimmu.2021.695815 · Cited by 18
Oda, H., Tanaka, S., Shinohara, M., Morimura, Y., Yokoyama, Y., Kayawake, H., Yamada, Y., Yutaka, Y., Ohsumi, A., Nakajima, D., et al. (2021) · Transplantation · doi:10.1097/tp.0000000000003987 · Cited by 15
“However, recent studies have shown that the resolution of inflammation is an active process caused by the biosynthesis of active mediators that promote the return to homeostasis.(12,13) Lipid mediators, which are involved in this process to actively resolve inflammation, are specialized proresolving lipid mediators (S…”
BackgroundThe endogenous control of acute inflammation – from onset to resolution
Gilroy, D. W. (2004) · Drug Discovery Today Therapeutic Strategies · doi:10.1016/j.ddstr.2004.11.017 · Cited by 20
Fierro, I. M. (2005) · Prostaglandins Leukotrienes and Essential Fatty Acids · doi:10.1016/j.plefa.2005.05.016 · Cited by 14
Nauseef, W. M., & Clark, R. A. (2010) · Elsevier eBooks · doi:10.1016/b978-0-443-06839-3.00008-4 · Cited by 13
Colgan, S. P., Comerford, K. M., & Lawrence, D. W. (2002) · The Scientific World JOURNAL · doi:10.1100/tsw.2002.77 · Cited by 14
Resolution Pharmacology: State-of-the-art and therapeutic landscape
Perretti, M., & Montero‐Melendez, T. (2025) · Pharmacological Reviews · doi:10.1016/j.pharmr.2025.100097 · Cited by 16
“85 These studies build on the original work of Levy et al 6 with RvE1 in a model of allergic lung inflammation.”
Risques associés à la prise d’anti-inflammatoires non stéroïdiens au cours de la pneumonie
Voiriot, G., Chalumeau, M., Messika, J., Basille, D., Philippe, B., Ricard, J.-D., Andrejak, C., Jounieaux, V., Sanchez, O., & Fartoukh, M. S. (2018) · Revue des Maladies Respiratoires · doi:10.1016/j.rmr.2017.12.003 · Cited by 17
Exploiting oxidized lipids and the lipid‐binding GPCRs against cardiometabolic diseases
Guimarães, R. C., Gonçalves, T. T., & Leiria, L. O. (2020) · British Journal of Pharmacology · doi:10.1111/bph.15321 · Cited by 17
“This step marks the switch in the lipid classes at the site of inflammation, thereby linking the acute inflammatory response with the resolution phase (Levy et al., 2001) (Figure 2).”
BackgroundInfluentialLipid-Derived Mediators are Pivotal to Leukocyte and Lung Cell Responses in Sepsis and ARDS
Nijmeh, J., & Levy, B. D. (2021) · Cell Biochemistry and Biophysics · doi:10.1007/s12013-021-01012-w · Cited by 13
Self-citationOxInflammation at High Altitudes: A Proof of Concept from the Himalayas
Mrakic‐Sposta, S., Biagini, D., Bondi, D., Pietrangelo, T., Vezzoli, A., Lomonaco, T., Francesco, F. D., & Verratti, V. (2022) · Antioxidants · doi:10.3390/antiox11020368 · Cited by 15
“Pro-inflammatory mediators released at the very beginning of inflammation foster the appearance of its classic signs, whereas the switch to lipoxygenase-derived antiinflammatory and pro-resolving mediators leads to a natural resolution of inflammation [15].”
BackgroundNing, Y., Wang, W., Jordan, P. M., Barth, S., Hofstetter, R. K., Xu, J., Zhang, X., Cai, Y., Menge, C., Chen, X., et al. (2023) · The Journal of Immunology · doi:10.4049/jimmunol.2200820 · Cited by 13
Specialized pro-resolving lipid mediators and resolution of viral diseases
Ferri, G., Mucci, M., Mattoscio, D., & Recchiuti, A. (2023) · Prostaglandins & Other Lipid Mediators · doi:10.1016/j.prostaglandins.2023.106762 · Cited by 13
Inflammation resolution and specialized pro-resolving lipid mediators in chronic rhinosinusitis
Robinson, P. Z., Frank, D. N., & Ramakrishnan, V. R. (2023) · Expert Review of Clinical Immunology · doi:10.1080/1744666x.2023.2232554 · Cited by 14
“Namely, LXA4 appears to be a self-regulatory mechanism acting to limit pro-inflammatory neutrophils to prevent overly-robust or prolonged pro-inflammatory responses to tissue injury [64].”
BackgroundResultAnghelache, M., Voicu, G., Deleanu, M., Turtoi, M., Safciuc, F., Anton, R., Boteanu, D., Fenyo, I. M., Mânduțeanu, I., Simionescu, M., et al. (2023) · Advanced Healthcare Materials · doi:10.1002/adhm.202302238 · Cited by 19
Smyth, M. D., Lunken, G., & Jacobson, K. (2023) · Journal of the Canadian Association of Gastroenterology · doi:10.1093/jcag/gwad058 · Cited by 15
“44,45 Notably, PGE2 limits inflammation by controlling cytokine levels (TNF-α , IL-1 β , and IL-6), 46 augmenting IL-10 secretion, 47 suppressing 5-LOX and inhibiting synthesis of LTs and inducing 15-LOX to promote the synthesis of LXs. 48,49 However, PGE2 has been reported to decrease the phagocytic activity of neutr…”
BackgroundRoles of Lipoxygenases in Cardiovascular Diseases
Liu, T., & Ai, D. (2025) · Journal of Cardiovascular Translational Research · doi:10.1007/s12265-025-10605-2 · Cited by 19
Zia, B., Elmeky, M., Azimullah, S., Jha, N. K., Meeran, M. F. N., & Ojha, S. K. (2025) · Current Neuropharmacology · doi:10.2174/011570159x365720250225080257 · Cited by 14
“The migration, recruitment, and adhesion of leukocytes at the site of inflammation are orchestrated by local vascular dynamics, including blood flow regulation, vascular capillary dilation, and permeability, which are intricately controlled by proinflammatory PGs and leukotrienes (LTs) [4, 5].”
Flak, M. B., Koenis, D. S., Gonzalez-Nuñez, M., Chopo-Pizarro, A., & Dalli, J. (2022) · Biochemical Pharmacology · doi:10.1016/j.bcp.2022.115348 · Cited by 13
Salivary lipid mediators: Key indexes of inflammation regulation in heart failure disease
Biagini, D., Ghimenti, S., Lenzi, A., Bonini, A., Vivaldi, F. M., Oger, C., Galano, J., Balas, L., Durand, T., Salvo, P., et al. (2023) · Free Radical Biology and Medicine · doi:10.1016/j.freeradbiomed.2023.03.015 · Cited by 14
Bürgin-Maunder, C., Brooks, P. R., & Russell, F. D. (2013) · Marine Drugs · doi:10.3390/md11114435 · Cited by 15
“One possibility is that AA, DHA and EPA are converted to lipoxin A4; resolvin D1, and resolvin E1, respectively, which have common pro-resolving activity [30,31].”
BackgroundFat as a physiological regulator: the news gets better
Calder, P. C., & Deckelbaum, R. J. (2003) · Current Opinion in Clinical Nutrition & Metabolic Care · doi:10.1097/00075197-200303000-00001 · Cited by 15
Oda, H. (2022) · Institutional Repositories DataBase (IRDB) · doi:10.14989/doctor.k23760 · Cited by 13
Sakurai, K., Chubachi, S., Miyata, J., Hamamoto, J., Naganuma, T., Shimada, T., Otake, S., Nakayama, S., Irie, H., Tsutsumi, A., et al. (2025) · Frontiers in Immunology · doi:10.3389/fimmu.2025.1557790 · Cited by 12
“These fi ndings partially explain the relationship between COX-2 inhibition and the impairment of 15-LOX metabolism (56).”
Adapa, S. R., Porshe, S., Talada, D. P., Nywening, T. M., Anderson, M. L., Shaw, T. I., & Jiang, R. H. Y. (2025) · Cancers · doi:10.3390/cancers17193210 · Cited by 13
“These metabolic shifts may be further intertwined with inflammatory lipid pathways [12,22–24], including ALOX5-mediated prostaglandin signaling, which has been implicated in tumor–stroma– immune crosstalk [22,24,25].”
Eudy, B. J., Odle, J., Lin, X., Maltecca, C., Walter, K. R., McNulty, N. P., Fellner, V., & Jacobi, S. K. (2023) · Journal of Nutrition · doi:10.1016/j.tjnut.2023.06.019 · Cited by 16
Li, J., Xiang, Q., Xia, T., Meng, H., & Liu, X. (2023) · Nano Today · doi:10.1016/j.nantod.2023.101978 · Cited by 14
Nischang, V., Witt, F., Börner, F., Gomez, M. F., Jordan, P. M., & Werz, O. (2024) · Frontiers in Pharmacology · doi:10.3389/fphar.2023.1332628 · Cited by 15
Exploring neuroinflammation: A key driver in neuropathic pain disorders
Scheuren, P. S., & Calvo, M. (2024) · International review of neurobiology · doi:10.1016/bs.irn.2024.10.009 · Cited by 18
Pascoal, L. B., Palma, B. B., Chaim, F. H. M., de Castro, M. M., Damázio, T. A., Franceschini, A. P. M. D. F., Milanski, M., Velloso, L. A., & Leal, R. F. (2022) · World Journal of Experimental Medicine · doi:10.5493/wjem.v12.i1.1 · Cited by 13
COVID-19 and cancer: start the resolution!
Barksdale, C., Kipper, F. C., Tripathy, S., Subbian, S., Serhan, C. N., & Panigrahy, D. (2022) · Cancer and Metastasis Reviews · doi:10.1007/s10555-021-10017-z · Cited by 14
Self-citationImpact of preweaning vaccination on host gene expression and antibody titers in healthy beef calves
Scott, M. A., Woolums, A. R., Karisch, B. B., Harvey, K. M., & Capik, S. F. (2022) · Frontiers in Veterinary Science · doi:10.3389/fvets.2022.1010039 · Cited by 13
“, lipoxins) (29) or from the metabolism of omega-3 and/or omega-6 essential polyunsaturated fatty acids (i.”
BackgroundDietary fatty acids, lipid mediators, immunity, and inflammation
Calder, P. C. (2023) · Elsevier eBooks · doi:10.1016/b978-0-443-15327-3.00003-3 · Cited by 16
Molecular Circuits of Resolution in Airway Inflammation
Carlo, T., & Levy, B. D. (2010) · The Scientific World JOURNAL · doi:10.1100/tsw.2010.143 · Cited by 14
“LXA4 is also present in exudative pleural effusions that are typically associated with lung or systemic inflammatory disease[61].”
BackgroundSelf-citationAïd, S., Parikh, N., Palumbo, S., & Bosetti, F. (2010) · Neuroscience Letters · doi:10.1016/j.neulet.2010.04.076 · Cited by 18
“We suggested that, because of its predominant localization in microglia, COX-1 may be the major player during endotoxin-induced neuroinflammation, and COX-2-derived products may be critical for timely resolution and termination of inflammation [12,19].”
BackgroundSaric, J. (2010) · Parasitology · doi:10.1017/s0031182010000697 · Cited by 13
“Some n-6 PUFA eicosanoids can act in an antiinflammatory manner (Levy et al. 2001; Vachier et al. 2002) and vice versa, PGE2 and PGE3 showed similarly effective inhibition of TNF-α and IL-1β (Dooper et al.”
BackgroundTHE ROLE OF LIPOXIN A4 IN CYSTIC FIBROSIS LUNG DISEASE
Urbach, V., Higgins, G., Buchanan, P., & Ringholz, F. (2013) · Computational and Structural Biotechnology Journal · doi:10.5936/csbj.201303018 · Cited by 15
Chaitidis, P., Kreutzer, F. J., Gerth, C., Janata, P., & Kühn, H. (2004) · Prostaglandins Leukotrienes and Essential Fatty Acids · doi:10.1016/j.plefa.2004.03.022 · Cited by 12
“For instance, lipoxins, the biosynthesis of which may involve the catalytic activity of 15-LOX1 [19,20], has been reported to act as anti-inflammatory mediator during the resolving phase of acute inflammation [21,22].”
BackgroundHomann, J., Suo, J., Schmidt, M., de Bruin, N. M. W. J., Scholich, K., Geißlinger, G., & Ferreirós, N. (2015) · PLoS ONE · doi:10.1371/journal.pone.0143141 · Cited by 13
“Additionally, PGE2 and PGD2, which are mainly regarded as pro-inflammatory lipid-mediators, were reported to promote resolution of inflammation by up-regulating the expression of 15-ALOX [44].”
Background
Metadata
- Authors
- Levy, B. D., Clish, C. B., Schmidt, B., Gronert, K., & Serhan, C. N.
- Affiliations
- Brigham and Women's Hospital (US)
- Corresponding author
- Serhan, Charles N.
- Venue
- Nature Immunology
- Published
- 2001-07
- Volume
- 2
- Issue
- 7
- Pages
- 612-619
- ISSN
- 1529-2908 (ISSN-L)
- 1529-2916
- OpenAlex
- W1497700962
- Cited by
- 1,453
- References
- 42
- Citations by year
- 2026: 48 · 2025: 60 · 2024: 61 · 2023: 74 · 2022: 74 · 2021: 81 · 2020: 76 · 2019: 64 · 2018: 69 · 2017: 62 · 2016: 62 · 2015: 63 · 2014: 62 · 2013: 69 · 2012: 60
- FWCI
- 33.62
- Type
- journal article
- Language
- en
- Open access
- closed
- Licence
- www.springer.com/tdm (tdm)
- Locations
- Nature Immunology (publishedVersion)
- PubMed (publishedVersion)
- Funders
- National Institutes of Health (5k08hl003788-04)
- National Heart, Lung, and Blood Institute (K08 HL 03788)
- National Institute of General Medical Sciences (GM 38765)
- National Institute of Allergy and Infectious Diseases (F32AI010389, F32-AI10389)
- National Institute of Diabetes and Digestive and Kidney Diseases (DK-50305, P01DK050305, K01DK060583)
- National Institute of Dental and Craniofacial Research (P01 DE 13499, P01DE013499)
- Topics
- Health Sciences › Nursing › Nutrition and Dietetics › Fatty Acid Research and Health
- Health Sciences › Medicine › Pharmacology (medical) › Inflammatory mediators and NSAID effects
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Biochemistry › Eicosanoids and Hypertension Pharmacology
- Keywords
- lipid mediators, acute inflammation, inflammation resolution, leukotrienes, prostaglandins, lipoxins, eicosanoid biosynthesis, neutrophil recruitment, lipoxin A4, leukotriene B4, 5-lipoxygenase, 15-lipoxygenase, prostaglandin E2, exudate, anti-inflammatory signaling
- MeSH terms
- Animals, Arachidonate 15-Lipoxygenase, Base Sequence, Humans, Hydroxyeicosatetraenoic Acids, Leukotriene B4, Lipids, Male, Mice, Inbred BALB C, Molecular Sequence Data, Neutrophils, Pleural Effusion, RNA, Messenger, Dinoprostone, Molecular Structure, Signal Transduction, DNA, Complementary, Lipoxins, Lipid Metabolism, Mice
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.